Dr. Prasad, the FDA’s Grim Reaper

The Wall Street JournalMonday, September 22, 2025 at 9:38:00 PM
NegativeU.S News
Dr. Prasad, the FDA’s Grim Reaper
The recent decision by the FDA to block a therapy for late-stage melanoma has raised serious concerns, as it could lead to the loss of many lives. This move has been criticized by experts, including Dr. Prasad, who argue that access to effective treatments is crucial for patients facing this aggressive cancer. The implications of this decision are significant, as it not only affects individual patients but also highlights broader issues within the healthcare system regarding the approval of life-saving therapies.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Cancer drug could double as autism therapy, and is poised for FDA approval
PositiveU.S News
Exciting news is emerging in the medical field as the cancer drug leucovorin is showing promise as a potential therapy for autism spectrum disorder. Health officials report that it may enhance communication skills in some children, which could significantly improve their quality of life. This development is particularly important as it opens new avenues for treatment options, and with FDA approval on the horizon, families may soon have access to this innovative approach.
Trump announces FDA will change Tylenol safety label, urges pregnant mothers to prevent autism risk in children: ‘Don’t take it!’
NegativeU.S News
President Trump has made a significant announcement urging pregnant women to avoid taking Tylenol throughout their pregnancy, citing studies that link the painkiller to an increased risk of autism in children. This statement raises concerns about the safety of widely used medications during pregnancy and highlights the need for further research and awareness on the potential risks associated with common drugs.
Trump claims acetaminophen use during pregnancy may cause autism, without clear proof
NegativeU.S News
President Trump recently made controversial claims regarding acetaminophen use during pregnancy, suggesting it may be linked to autism, a statement that lacks clear scientific proof. This assertion comes alongside the FDA's warning about the potential risks associated with acetaminophen, raising concerns among expectant mothers and health professionals. The implications of such claims can lead to increased anxiety and confusion about medication safety during pregnancy, highlighting the need for clear communication and evidence-based guidance in public health.
Trump: FDA advises use of acetaminophen during pregnancy increases chance of autism
NegativeU.S News
President Trump has revealed that the FDA will recommend against the use of acetaminophen during pregnancy, citing concerns over a potential increase in autism risk. This announcement is significant as it could impact the choices of expectant mothers and raise awareness about medication safety during pregnancy.
Latest from U.S News
Navigating 8 months of Donald Trump’s tariffs has been ‘extremely challenging’, lawyer says
NegativeU.S News
Martha Harrison, a lawyer, recently shared insights on the significant challenges faced by businesses due to Donald Trump's tariffs over the past eight months. She highlighted how these tariffs have dramatically impacted their client base, creating a volatile environment in international trade. This situation matters because it underscores the broader implications of trade policies on economic stability and business operations.
Jay Jacobs’ courageous Mamdani opposition: Letters to the Editor — Sept. 23, 2025
PositiveU.S News
In a recent discussion among NY Post readers, New York Democratic Chairman Jay Jacobs has taken a bold stance against mayoral nominee Zohran Mamdani. This opposition highlights the ongoing debates within the party and reflects the diverse opinions shaping the upcoming election. Jacobs' willingness to voice his concerns is significant as it underscores the importance of leadership and accountability in political nominations, making it a topic of interest for voters.
Supreme Court upholds FTC firings
NeutralU.S News
The Supreme Court has decided to review a longstanding precedent that allows Congress to grant certain agencies independence from the executive branch. This move could significantly impact the Federal Trade Commission (FTC) and other agencies, as it challenges the balance of power between Congress and the White House. The outcome of this case is crucial as it may redefine the operational autonomy of federal agencies, influencing how they function and enforce regulations in the future.
LI man charged in $3M theft from missing couple on the run after ditching federal court appearance
NegativeU.S News
Yinye Wang and Quiju Wu have been charged with stealing $3 million from a missing couple from Long Island, but only Wu appeared in federal court. This case highlights the troubling issue of theft and deception, especially when it involves vulnerable individuals. The absence of Wang raises questions about accountability and the ongoing investigation into the couple's disappearance.
Trump signs executive order designating Antifa a ‘domestic terrorist organization’
NegativeU.S News
In a significant move, President Trump has signed an executive order designating Antifa as a 'domestic terrorist organization.' This decision follows his previous hints about labeling the radical anti-fascist group as a terror entity. The implications of this order are profound, as it could lead to increased scrutiny and potential legal actions against individuals associated with Antifa, raising concerns about civil liberties and the government's approach to dissent.
Recognizing ‘Palestine’ rewards Hamas, and spits in the face of Israeli hostages
NegativeU.S News
The recent recognition of 'Palestine' has sparked outrage as it is seen as a reward for Hamas, which continues to taunt the international community. This move not only undermines the plight of Israeli hostages but also raises concerns about the implications for peace in the region. It's a contentious issue that highlights the complexities of the Israeli-Palestinian conflict and the challenges of achieving a lasting resolution.